Topic · page 8 of 40

Rheumatoid arthritis

Early and established rheumatoid arthritis in adults: diagnosis and prediction (clinically suspect arthralgia, people at risk), treat-to-target, conventional, biologic and targeted synthetic drugs, tapering and withdrawal, glucocorticoids, extra-articular disease and rheumatoid arthritis–associated interstitial lung disease

Briefs 281–320 of 1,564 placed here, newest publication first

Briefs in Rheumatoid arthritis

Newest publication first

Scand J Rheumatol23 Jan 2026
Oral glucocorticoid premedication for preventing infusion-related reactions to rituximab in rheumatoid arthritis
Cohort study
Semin Arthritis Rheum22 Jan 2026
Hormone therapy in menopause increases rheumatoid arthritis risk: A systematic review and meta-analysis
Meta-analysis
RMD Open22 Jan 2026
Mapping the bare area and transcortical pores in finger joints: co-location with bone erosions in rheumatoid arthritis
Cross-sectional study
RMD Open22 Jan 2026
RA-risk synovium exhibits DNA damage coupled with impaired DNA repair in fibroblasts
Mechanistic study
Lancet Rheumatol21 Jan 2026
Strengthening patient and public involvement in digital health innovation: reflective analysis of the development and real-world testing of the MyRA application
Cohort study
Arthritis Care Res (Hoboken)20 Jan 2026
Accuracy of Diagnostic Codes and Algorithms Used to Identify Rheumatoid Arthritis and Juvenile Idiopathic Arthritis in Administrative Claims and Electronic Health Records: Systematic Review and Meta‐Analysis
Meta-analysis
Lancet Rheumatol20 Jan 2026
Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial
Randomized controlled trial
RMD Open20 Jan 2026
Which arthralgia patients benefit most in reduction of subclinical joint inflammation by methotrexate treatment: results from the TREAT EARLIER trial
Secondary analysis
Rheumatology (Oxford)18 Jan 2026
Heterogeneity in the association of genetic risk for RA and resultant RA phenotypes
Cohort study
Rheumatology (Oxford)18 Jan 2026
Cytokine/chemokine profiles in rheumatoid arthritis patients who failed Boolean remission solely due to elevated patient global assessment
Cohort study
Rheumatology (Oxford)18 Jan 2026
Progressive interstitial lung disease associated with rheumatoid arthritis and abatacept: data from a multicentre cohort of 526 patients
Cohort study
Clin Exp Rheumatol17 Jan 2026
Identification of intestinal biomarkers for evaluating disease activity in rheumatoid arthritis
Diagnostic or prognostic study
RMD Open16 Jan 2026
Comparison of tofacitinib, baricitinib, upadacitinib and filgotinib: a 2-year observational study from FIRST registry
Cohort study
RMD Open16 Jan 2026
Predicting the progression of difficult-to-treat rheumatoid arthritis by a machine learning scoring system, from the FIRST registry
Diagnostic or prognostic study
Arthritis Care Res (Hoboken)16 Jan 2026
Objectively Measured Sleep Disorders in Rheumatoid Arthritis and Their Association With Disease Activity
Cohort study
J Rheumatol15 Jan 2026
Stressful Life Events in the Year Prior to Diagnosis and Associations With Rheumatoid Arthritis Characteristics at Presentation and 1 Year Later
Cohort study
Clin Exp Rheumatol15 Jan 2026
Association of the rs7574865 polymorphism in the signal transducer and activator of transcription 4 gene with rheumatoid arthritis in Moroccan patients
Case-control study
Rheumatology (Oxford)14 Jan 2026
A head-to-head comparison of TNF-α inhibitors as the first biologic treatment of rheumatoid arthritis
Cohort study
Semin Arthritis Rheum12 Jan 2026
Predictors of achieving clinical remission in ACPA-positive RA-patients treated with abatacept and methotrexate and methotrexate monotherapy: a post-hoc analysis of the AVERT and AVERT-II trials
Secondary analysis
Clin Exp Rheumatol12 Jan 2026
Determinants of subclinical cardiovascular remodelling measured by carotid intima-media thickness in early rheumatoid arthritis: a longitudinal analysis
Cohort study
Semin Arthritis Rheum11 Jan 2026
Risk of ILD and safety outcomes across DMARD classes in rheumatoid arthritis and RA-ILD
Cohort study
Arthritis Rheumatol11 Jan 2026
Distinct HLA Associations for Antibody Multireactivity With Citrulline‐Containing Type II Collagen Epitopes Versus More Limited Antibody Reactivity With Citrulline‐Containing IgG Epitopes in Rheumatoid Arthritis
Cross-sectional study
Arthritis Rheumatol11 Jan 2026
Performance of an Idiopathic Pulmonary Fibrosis–Derived Multibiomarker Panel for Rheumatoid Arthritis–Associated Interstitial Lung Disease
Diagnostic or prognostic study
Arthritis Res Ther10 Jan 2026
Microvascular imaging is superior to power doppler in synovitis vascular flow detection in rheumatoid arthritis using the OMERACT-EULAR scoring system
Cross-sectional study
RMD Open8 Jan 2026
Effects of upadacitinib or adalimumab on pain in rheumatoid arthritis and psoriatic arthritis: results from randomised phase 3 studies
Secondary analysis
Rheumatology (Oxford)8 Jan 2026
Work-related physical strain as novel risk factor for the severity of joint inflammation at diagnosis of anti-citrullinated protein antibodies–positive rheumatoid arthritis
Cohort study
Arthritis Care Res (Hoboken)6 Jan 2026
Detection of Lung Abnormalities in Patients With Rheumatoid Arthritis Who Smoke and Who Were Screened for Lung Cancer With Low‐Dose Chest Computed Tomography Imaging in Routine Clinical Care: Results From a Large Multihospital System
Cross-sectional study
Arthritis Res Ther2 Jan 2026
Real-world comparative effectiveness of sarilumab versus Janus kinase inhibitors as monotherapy in rheumatoid arthritis
Cohort study
Semin Arthritis Rheum29 Dec 2025
Characteristics and long-term outcomes of patients with rheumatoid arthritis and concurrent calcium pyrophosphate deposition disease
Cohort study
Clin Exp Rheumatol28 Dec 2025
The impact of biological and targeted synthetic disease-modifying antirheumatic drugs on patient costs: a cross-sectional study
Cross-sectional study
Ann Rheum Dis25 Dec 2025
Inflammation rather than anticitrullinated protein antibodies is associated with cardiovascular mortality in RA: insights from rheumatoid arthritis and coronary artery disease cohorts
Cohort study
Joint Bone Spine22 Dec 2025
Treatment sequences of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: A nationwide population-based study in France
Cohort study
Arthritis Res Ther19 Dec 2025
Safety of JAK inhibitors versus other biologic therapies following anti-TNF failure in patients with rheumatoid arthritis
Cohort study
Ann Rheum Dis18 Dec 2025
Development and validation of a model to predict the disease activity score: towards a remote treat-to-target approach for rheumatoid arthritis
Diagnostic or prognostic study
RMD Open17 Dec 2025
Comparison of long-term efficacy, tolerability and drug survival rates of baricitinib as monotherapy or combination therapy in RA patients: data from a real-world prospective cohort study
Cohort study
Arthritis Care Res (Hoboken)16 Dec 2025
Clinical Outcomes of Patients Within the Rheumatoid Arthritis Care Pathway Cohort at a Tertiary Care Integrated Delivery Network: A Comparison to Usual Care
Cohort study
Arthritis Care Res (Hoboken)15 Dec 2025
Financial Distress and Its Determinants in Rheumatoid Arthritis
Cross-sectional study
Semin Arthritis Rheum13 Dec 2025
Exploring factors contributing to frailty in Chinese patients with rheumatoid arthritis: Validation of a tailored assessment tool
Cross-sectional study
RMD Open11 Dec 2025
Efficacy of ozoralizumab in rheumatoid arthritis patients with large joint involvement: a post hoc analysis of OHZORA and NATSUZORA trials
Secondary analysis
Arthritis Care Res (Hoboken)9 Dec 2025
Evaluating the Longitudinal Association of Rheumatoid Arthritis Disease Activity With Phenotypic Frailty: Evidence for Secondary Frailty?
Cohort study

All 1,564 Briefs in ExploreShowing Briefs 281–320 of 1,564, newest first